Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
Recruiting
Phase 3
Interventional Study
Chronic Pain
Prescription Opioid Misuse
Substance-Related Disorders
Pain
Narcotic-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Opioid-Related Disorders
Neurologic Manifestations
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 300 (estimated)
- Sponsor
- University of Utah · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary aim of this implementation-effectiveness trial is to examine the effectiveness of Mindfulness-Oriented Recovery Enhancement (MORE) and patient-centered chronic pain management visits in primary care as interventions to reduce chronic pain, improve quality of life, and reduce opioid-related harms among chronic pain patients on long-term opioid therapy.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18 +
* Current chronic pain diagnosis (pain for ≥3 months) determined by physician assessment
* Prescribed long-term opioid therapy (≥3 months)
* Score \>=3 on the Pain Enjoyment General Activity scale
* Score \>=9 on the Current Opioid Misuse Measure OR lifetime psychiatr…
Contacts